Every 8-K that Aimfinity Investment Corp I (AIMUF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow AIMUF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIMUF filings page.
Aimfinity Investment Corp. I reports additional governance and business developments tied to its pending business combination with Docter Inc. The future public company (PubCo) plans to add two independent directors, William Frank Koschak and Jonathan Bond, who will also sit on the audit, compensation, and nominating and governance committees. The board has determined that both are independent under Nasdaq rules and that Koschak qualifies as an audit committee financial expert.
The filing also highlights early commercial traction for Docter. Docter completed a first shipment to a Taiwan SECOM subsidiary valued at about NT$1.66 million, which management describes as part of a broader project estimated at approximately NT$75 million. A separate customized order from Leeway Biomedical covers 300 iCARE sleep sensing devices worth roughly NT$2,268,000, with discussions indicating potential expansion to about 10,000 units and projected total sales of around USD 2.5 million if testing is successful. Docter additionally outlines several hospital projects expected to move forward over the next three months using its mmWave technology, all subject to competitive public tenders with no assurance of award. Independent directors of PubCo are expected to receive annual compensation of 20,000 PubCo Ordinary Shares.
Aimfinity Investment Corp. I disclosed that its sponsor’s designee, I‑Fa Chang, deposited $500 into the SPAC’s trust account on both March 28, 2026 and April 28, 2026, triggering one‑month extensions of the deadline to complete its initial business combination, first to April 28, 2026 and then to May 28, 2026.
These were the sixth and seventh of up to nine permitted monthly extensions under the current charter, each requiring a $500 deposit. In connection with these and prior loans, the company issued an unsecured promissory note dated May 5, 2026 to Mr. Chang with a principal amount of up to $2,000, of which $1,000 had been drawn as of May 6, 2026.
The note bears no regular interest, with default interest tied to the prevailing short‑term U.S. Treasury Bill rate, and is repayable upon completion of Aimfinity’s initial business combination or liquidation. Under an exchange agreement related to Aimfinity’s planned business combination with Docter Inc., any outstanding balance on the note at closing will automatically convert into PubCo ordinary shares at a conversion price of $10.00 per share. The note was issued under a private offering exemption from registration.
Aimfinity Investment Corp. I entered into a small financing arrangement to extend the deadline for completing its initial business combination. On February 28, 2026, the company issued an unsecured promissory note for $500 to I-Fa Chang, designated by the sponsor, and deposited the same amount into its trust account as a monthly extension payment.
This fifth of up to nine allowed extensions moves the business combination deadline from February 28, 2026 to March 28, 2026. Under an existing exchange agreement, the note balance will automatically convert into PubCo ordinary shares at $10.00 per share upon closing the proposed business combination with Docter Inc., unless repaid earlier. The note was issued under a private placement exemption, and the company also released a press statement announcing the extension.
Aimfinity Investment Corp. I disclosed that it issued an unsecured promissory note for $500 to I-Fa Chang, the sponsor’s designee, to fund a monthly extension payment into the trust account for public shareholders. This payment extends the deadline to complete its initial business combination by one month, from January 28, 2026 to February 28, 2026.
The new extension is the fourth of up to nine one‑month extensions authorized under a prior charter amendment, each requiring a $500 deposit into the trust account. Upon closing of the proposed business combination with Docter Inc., any unpaid balance of the note will automatically convert into PubCo ordinary shares at a conversion price of $10.00 per share. The note was issued under a Section 4(a)(2) exemption, and the company also furnished a press release announcing the extension.
Aimfinity Investment Corp. I disclosed that it issued a $500 unsecured promissory note to I-Fa Chang, a manager of its sponsor’s LLC, to fund a monthly extension payment into the SPAC trust account. This payment allows Aimfinity to extend the deadline to complete its initial business combination by one month, from December 28, 2025 to January 28, 2026, representing the third of up to nine one‑month extensions authorized under a prior charter amendment.
Under an existing exchange agreement, the note’s outstanding balance will automatically convert into PubCo ordinary shares at $10.00 per share if the business combination between Aimfinity and Docter Inc. closes, unless repaid earlier. The note was issued under a private offering exemption from registration, and the company also furnished a press release announcing the new extension while reiterating extensive forward‑looking statement and transaction risk disclosures.
Aimfinity Investment Corp. I disclosed that shareholders approved changes to its charter that let the company extend the deadline to complete its initial business combination in one-month increments, up to nine months, to July 28, 2026, by depositing $500 into its trust account for each extension. The charter was also amended to remove the requirement that any business combination leave the company with at least $5,000,001 of net tangible assets.
On November 28, 2025, Aimfinity issued an unsecured promissory note for $500 to I-Fa Chang, designated by the sponsor, to fund the first new monthly extension, moving the transaction deadline from November 28, 2025 to December 28, 2025. Upon closing of its proposed business combination with Docter Inc., any unpaid balance of this note will automatically convert into PubCo ordinary shares at a price of $10.00 per share.